Diagnosis of acquired generalized lipodystrophy in a single patient with T-cell lymphoma and no exposure to Metreleptin

Diagnosis of acquired generalized lipodystrophy in a single patient with T-cell lymphoma and no exposure to Metreleptin

Abstract Background Metreleptin, a recombinant methionyl -human -leptin, was approved to treat patients with generalized lipodystrophy (GL) in February 2014. However, leptin therapy has been associated with the development of lymphoma. We present a unique case of a patient with prior history of T ce...

Full description

Bibliographic Details
Main Authors: Nazanene H. Esfandiari, Melvyn Rubenfire, Adam H. Neidert, Rita Hench, Abdelwahab Jalal Eldin, Rasimcan Meral, Elif A. Oral
Format: Article
Language:English
Published: BMC 2019-03-01
Series:Clinical Diabetes and Endocrinology
Subjects:
T-cell lymphoma
Acquired generalized lipodystrophy
Insulin resistance
Diabetes
Leptin
Online Access:http://link.springer.com/article/10.1186/s40842-019-0076-9

Internet

http://link.springer.com/article/10.1186/s40842-019-0076-9

Similar Items